The NIAID has a considerable research programdedicated to fighting antibiotic resistant bacteria and the agency awards grants to deserving companies that focus on the identification of new antimicrobials to fight threatening superbugs.
The deal underpins the importance that slow-growing technology giants place on faster-growing, web-based software makers, whose products are less vulnerable to the economic downturn as there are no upfront costs for program licenses, dedicated hardware or installation.